SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BOU'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 389 LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528	BOU A 584 (-1.4A) BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A)	0.39A	1ghmA-3q7zA: 17.8	1ghmA-3q7zA: 26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK3_A_T44A3003_1 (SERUM ALBUMIN)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	3 / 4	LYS A 392 ALA A 396 MET A 434	BOU A 584 ( 3.9A) None None	1.05A	1hk3A-3q7zA: undetectable	1hk3A-3q7zA: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 389 LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528	BOU A 584 (-1.4A) BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A)	0.43A	1i2wA-3q7zA: 18.3	1i2wA-3q7zA: 22.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 (-1.4A) BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.46A	1ymxA-3q7zA: 18.2	1ymxA-3q7zA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 (-1.4A) BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.42A	1ymxB-3q7zA: 18.2	1ymxB-3q7zA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X0P_A_ADNA1607_1 (ALCALIGIN BIOSYNTHESIS PROTEIN)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	4 / 8	GLY A 528 ILE A 531 ALA A 568 HIS A 557	BOU A 584 (-3.7A) BOU A 584 (-3.8A) None None	0.92A	2x0pA-3q7zA: undetectable	2x0pA-3q7zA: 15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.43A	3hlwA-3q7zA: 18.2	3hlwA-3q7zA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528 GLY A 530	BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.30A	3hlwB-3q7zA: 18.2	3hlwB-3q7zA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	LYS A 392 ASN A 439 LYS A 526 THR A 527 GLY A 528 GLY A 530	BOU A 584 ( 3.9A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.40A	3huoA-3q7zA: 18.1	3huoA-3q7zA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	5 / 12	LYS A 392 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 ( 3.9A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.43A	3huoB-3q7zA: 18.1	3huoB-3q7zA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP2_A_PNNA5001_0 (TRANSCRIPTIONAL REGULATOR TCAR)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	4 / 8	ASN A 388 THR A 390 HIS A 557 ASN A 537	BOU A 584 (-4.5A) None None None	1.07A	3kp2A-3q7zA: undetectable 3kp2B-3q7zA: undetectable	3kp2A-3q7zA: 18.90 3kp2B-3q7zA: 18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.56A	3ny4A-3q7zA: 17.7	3ny4A-3q7zA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.34A	3q07A-3q7zA: 18.0	3q07A-3q7zA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.53A	3q07B-3q7zA: 18.0	3q07B-3q7zA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 389 SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A)	0.34A	3sh8A-3q7zA: 18.5	3sh8A-3q7zA: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 389 LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528	BOU A 584 (-1.4A) BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A)	0.41A	3sh8B-3q7zA: 18.8	3sh8B-3q7zA: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	LYS A 392 SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528 THR A 529	BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A)	0.60A	4euzA-3q7zA: 17.9	4euzA-3q7zA: 23.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	5 / 10	SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528	BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A)	0.53A	4fh2A-3q7zA: 17.0	4fh2A-3q7zA: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 389 SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A)	0.29A	4n9kA-3q7zA: 18.5	4n9kA-3q7zA: 22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 389 SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A)	0.29A	4n9kB-3q7zA: 18.6	4n9kB-3q7zA: 22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528 GLY A 530	BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.64A	4pm5A-3q7zA: 18.0	4pm5A-3q7zA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	LYS A 392 SER A 437 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 ( 3.9A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.72A	4pm7A-3q7zA: 18.1	4pm7A-3q7zA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528 GLY A 530	BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.66A	4pm9A-3q7zA: 18.2	4pm9A-3q7zA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	5 / 12	SER A 389 SER A 437 ASN A 439 LYS A 526 GLY A 528	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A)	0.31A	5ghyB-3q7zA: 18.6	5ghyB-3q7zA: 22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 11	SER A 389 SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A)	0.30A	5ghzA-3q7zA: 18.6	5ghzA-3q7zA: 22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 10	SER A 389 SER A 437 ASN A 439 LYS A 526 THR A 527 GLY A 528	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A)	0.33A	5ghzB-3q7zA: 18.5	5ghzB-3q7zA: 22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.50A	6b5yB-3q7zA: 17.9	6b5yB-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.52A	6b5yD-3q7zA: 17.7	6b5yD-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.38A	6b68B-3q7zA: 17.8	6b68B-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	6 / 12	SER A 389 SER A 437 LYS A 526 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.43A	6b68D-3q7zA: 17.7	6b68D-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.38A	6b69A-3q7zA: 17.8 6b69B-3q7zA: 17.3	6b69A-3q7zA: 14.22 6b69B-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.35A	6b69D-3q7zA: 17.6	6b69D-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.41A	6b6aB-3q7zA: 17.7	6b6aB-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.38A	6b6aD-3q7zA: 17.6	6b6aD-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.47A	6b6cA-3q7zA: 17.7	6b6cA-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.57A	6b6dA-3q7zA: 17.6	6b6dA-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.43A	6b6eA-3q7zA: 17.7	6b6eA-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	7 / 12	SER A 389 SER A 437 LYS A 526 THR A 527 GLY A 528 THR A 529 GLY A 530	BOU A 584 (-1.4A) BOU A 584 (-2.8A) BOU A 584 (-3.3A) BOU A 584 (-3.6A) BOU A 584 (-3.7A) BOU A 584 (-3.6A) BOU A 584 ( 3.9A)	0.55A	6b6fA-3q7zA: 17.5	6b6fA-3q7zA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	3q7z	BETA-LACTAMASE REGULATORY PROTEIN BLAR1 (Staphylococcus aureus)	5 / 12	SER A 437 ASN A 439 LYS A 526 GLY A 528 GLY A 530	BOU A 584 (-2.8A) BOU A 584 (-3.5A) BOU A 584 (-3.3A) BOU A 584 (-3.7A) BOU A 584 ( 3.9A)	0.30A	6c79A-3q7zA: 18.4	6c79A-3q7zA: 16.38

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528","BOU A 584 (-1.4A);BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A)","0.39A","1ghmA-3q7zA:17.8",null],["1HK3_A_T44A3003_1","SERUM ALBUMIN","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",3,"LYS A 392;ALA A 396;MET A 434","BOU A 584 ( 3.9A);None;None","1.05A","1hk3A-3q7zA:undetectable","1ghmA-3q7zA:26.33"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528","BOU A 584 (-1.4A);BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A)","0.43A","1i2wA-3q7zA:18.3","1hk3A-3q7zA:17.77"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 (-1.4A);BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.46A","1ymxA-3q7zA:18.2","1i2wA-3q7zA:22.95"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 (-1.4A);BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.42A","1ymxB-3q7zA:18.2","1ymxA-3q7zA:20.35"],["2X0P_A_ADNA1607_1","ALCALIGIN BIOSYNTHESIS PROTEIN","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",4,"GLY A 528;ILE A 531;ALA A 568;HIS A 557","BOU A 584 (-3.7A);BOU A 584 (-3.8A);None;None","0.92A","2x0pA-3q7zA:undetectable","1ymxB-3q7zA:20.35"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.43A","3hlwA-3q7zA:18.2","2x0pA-3q7zA:15.19"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528;GLY A 530","BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.30A","3hlwB-3q7zA:18.2","3hlwA-3q7zA:20.00"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"LYS A 392;ASN A 439;LYS A 526;THR A 527;GLY A 528;GLY A 530","BOU A 584 ( 3.9A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.40A","3huoA-3q7zA:18.1","3hlwB-3q7zA:20.00"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",5,"LYS A 392;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 ( 3.9A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.43A","3huoB-3q7zA:18.1","3huoA-3q7zA:20.00"],["3KP2_A_PNNA5001_0","TRANSCRIPTIONAL REGULATOR TCAR","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",4,"ASN A 388;THR A 390;HIS A 557;ASN A 537","BOU A 584 (-4.5A);None;None;None","1.07A","3kp2A-3q7zA:undetectable;3kp2B-3q7zA:undetectable","3huoB-3q7zA:20.00"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.56A","3ny4A-3q7zA:17.7","3kp2A-3q7zA:18.90;3kp2B-3q7zA:18.90"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.34A","3q07A-3q7zA:18.0","3ny4A-3q7zA:21.52"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.53A","3q07B-3q7zA:18.0","3q07A-3q7zA:20.00"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A)","0.34A","3sh8A-3q7zA:18.5","3q07B-3q7zA:20.00"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528","BOU A 584 (-1.4A);BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A)","0.41A","3sh8B-3q7zA:18.8","3sh8A-3q7zA:23.08"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"LYS A 392;SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528;THR A 529","BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A)","0.60A","4euzA-3q7zA:17.9","3sh8B-3q7zA:23.08"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",5,"SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528","BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A)","0.53A","4fh2A-3q7zA:17.0","4euzA-3q7zA:23.73"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A)","0.29A","4n9kA-3q7zA:18.5","4fh2A-3q7zA:20.89"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A)","0.29A","4n9kB-3q7zA:18.6","4n9kA-3q7zA:22.73"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528;GLY A 530","BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.64A","4pm5A-3q7zA:18.0","4n9kB-3q7zA:22.73"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"LYS A 392;SER A 437;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 ( 3.9A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.72A","4pm7A-3q7zA:18.1","4pm5A-3q7zA:20.35"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528;GLY A 530","BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.66A","4pm9A-3q7zA:18.2","4pm7A-3q7zA:20.35"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",5,"SER A 389;SER A 437;ASN A 439;LYS A 526;GLY A 528","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A)","0.31A","5ghyB-3q7zA:18.6","4pm9A-3q7zA:20.00"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A)","0.30A","5ghzA-3q7zA:18.6","5ghyB-3q7zA:22.73"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;SER A 437;ASN A 439;LYS A 526;THR A 527;GLY A 528","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A)","0.33A","5ghzB-3q7zA:18.5","5ghzA-3q7zA:22.73"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.50A","6b5yB-3q7zA:17.9","5ghzB-3q7zA:22.73"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.52A","6b5yD-3q7zA:17.7","6b5yB-3q7zA:14.22"],["6B68_B_9F2B301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.38A","6b68B-3q7zA:17.8","6b5yD-3q7zA:14.22"],["6B68_D_9F2D400_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",6,"SER A 389;SER A 437;LYS A 526;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.43A","6b68D-3q7zA:17.7","6b68B-3q7zA:14.22"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.38A","6b69A-3q7zA:17.8;6b69B-3q7zA:17.3","6b68D-3q7zA:14.22"],["6B69_D_9F2D301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.35A","6b69D-3q7zA:17.6","6b69A-3q7zA:14.22;6b69B-3q7zA:14.22"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.41A","6b6aB-3q7zA:17.7","6b69D-3q7zA:14.22"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.38A","6b6aD-3q7zA:17.6","6b6aB-3q7zA:14.22"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.47A","6b6cA-3q7zA:17.7","6b6aD-3q7zA:14.22"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.57A","6b6dA-3q7zA:17.6","6b6cA-3q7zA:14.22"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.43A","6b6eA-3q7zA:17.7","6b6dA-3q7zA:14.22"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",7,"SER A 389;SER A 437;LYS A 526;THR A 527;GLY A 528;THR A 529;GLY A 530","BOU A 584 (-1.4A);BOU A 584 (-2.8A);BOU A 584 (-3.3A);BOU A 584 (-3.6A);BOU A 584 (-3.7A);BOU A 584 (-3.6A);BOU A 584 ( 3.9A)","0.55A","6b6fA-3q7zA:17.5","6b6eA-3q7zA:14.22"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","3q7z","BETA-LACTAMASE REGULATORY PROTEIN BLAR1","Staphylococcus aureus",5,"SER A 437;ASN A 439;LYS A 526;GLY A 528;GLY A 530","BOU A 584 (-2.8A);BOU A 584 (-3.5A);BOU A 584 (-3.3A);BOU A 584 (-3.7A);BOU A 584 ( 3.9A)","0.30A","6c79A-3q7zA:18.4","6b6fA-3q7zA:14.22"]]